CRISPR/Cas9 system: a novel approach to overcome chemotherapy and radiotherapy resistance in cancer
Crossref DOI link: https://doi.org/10.1007/s00210-024-03480-2
Published Online: 2024-11-19
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Noruzi, Somaye
Mohammadi, Rezvan
Jamialahmadi, Khadijeh
Text and Data Mining valid from 2024-11-19
Version of Record valid from 2024-11-19
Article History
Received: 24 July 2024
Accepted: 21 September 2024
First Online: 19 November 2024
Declarations
:
: The authors declare no competing interests.